Table 5 Reported minor adverse events throughout the course of study in the MTrP-DN and S-DN group
Event | Number reported | Percentage per total treatments |
|---|---|---|
Bleeding | 29 | 67.5% |
Bruising | 17 | 39.5% |
Pain during | 26 | 60.5% |
Pain after | 17 | 39.5% |
Aggravated symptoms | 0 | 0% |
Drowsiness | 2 | 4.6% |
Feeling faint | 0 | 0% |
Headache | 0 | 0% |
Nausea | 0 | 0% |